Conservest Capital Advisors’s JPMorgan International Research Enhanced Equity ETF JIRE Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$75.5M Sell
915,678
-1,141
-0.1% -$91.6K 6.01% 4
2026
Q1
$69.4M Buy
916,819
+39,936
+5% +$3.12M 6.29% 4
2025
Q4
$65.7M Buy
876,883
+52
+0% +$3.88K 5.92% 5
2025
Q3
$64.5M Buy
876,831
+8,653
+1% +$621K 5.97% 5
2025
Q2
$61.4M Sell
868,178
-7,174
-0.8% -$478K 6.07% 5
2025
Q1
$55.8M Buy
875,352
+865,440
+8,731% +$54.2M 5.86% 5
2024
Q4
$580K Buy
+9,912
New +$619K 0.06% 65

Other funds holding JIRE

Conservest Capital Advisors's JIRE Position: Q2 2026 in Review

Conservest Capital Advisors reduced its JPMorgan International Research Enhanced Equity ETF (JIRE) stake by 0.12% in Q2 2026, selling an estimated $91.6K and leaving 915,678 shares worth $75.5M. The position accounts for 6.01% of the portfolio, ranked #4.

Conservest Capital Advisors first reported a position in JIRE in Q4 2024 and has held it in 7 quarters since. 161 funds tracked by Wall St. Rank hold JIRE as of Q2 2026.

  • Conservest Capital Advisors held 915,678 shares of JPMorgan International Research Enhanced Equity ETF worth $75.5M as of Q2 2026.
  • Conservest Capital Advisors sold 1,141 JPMorgan International Research Enhanced Equity ETF shares in Q2 2026, an estimated $91.6K.
  • JPMorgan International Research Enhanced Equity ETF made up 6.01% of Conservest Capital Advisors's portfolio in Q2 2026, its #4 holding.
  • Conservest Capital Advisors first reported a position in JPMorgan International Research Enhanced Equity ETF in Q4 2024 and has held it in 7 quarters since.
  • 161 funds tracked by Wall St. Rank held JPMorgan International Research Enhanced Equity ETF as of Q2 2026.

Based on Conservest Capital Advisors's 13F filing for Q2 2026, filed 22 Jul 2026.